Colorectal

Oncology·MeSH: Thyroid Neoplasms

Prevalence

135.0 / 100K

Incidence

36.0 / 100K/yr

357 drugs in development·96 companies·1 clinical trial

Drug Pipeline by Phase

Approved(16)

Drug	Company
alymsys	Amneal Pharmaceuticals, Inc. (AMRX)
calcium gluconate in	Amneal Pharmaceuticals, Inc. (AMRX)
Cyramza	ELI LILLY & Co (LLY)
Cyramza®	ELI LILLY & Co (LLY)
Erbitux	ELI LILLY & Co (LLY)
Erbitux®	ELI LILLY & Co (LLY)
krazati	BRISTOL MYERS SQUIBB CO (BMY)
leucovorin calcium preservative free	Mylan II B.V. (MYL)
leucovorin calcium preservative free	Seagen Inc. (SGEN)
levoleucovorin	Amneal Pharmaceuticals, Inc. (AMRX)
menacalc	METASTAT, INC. (MTST)
ssi mantra	SS Innovations International Inc. (SSII)
tukysa	Seagen Inc. (SGEN)
vykoura	Kaya Holdings, Inc. (KAYS)
zaltrap	Sanofi (SNY)
zaltrap	Sanofi (SNY)

Phase 3(87)

Drug	Company
A10 and AS2-1 Antineoplaston	BURZYNSKI RESEARCH INSTITUTE INC (BZYR)
Adjuvant Systemic Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
Amivantamab	REGENXBIO Inc. (RGNX)
Amivantamab	Amneal Pharmaceuticals, Inc. (AMRX)
Amivantamab + FOLFIRI	IGM Biosciences, Inc. (IGMS)
Amivantamab and Recombinant Human Hyaluronidase	Amneal Pharmaceuticals, Inc. (AMRX)
amivantamab sc	GH Research PLC (GHRS)
Avelumab	IGM Biosciences, Inc. (IGMS)
BET Bromodomain Inhibitor ZEN-3694	Merus N.V. (MRUS)
Biweekly FOLFIRI	IGM Biosciences, Inc. (IGMS)
blood intake	Cidara Therapeutics, Inc. (CDTX)
BNT314	BioNTech SE (BNTX)
Calcium folinate	IGM Biosciences, Inc. (IGMS)
Calcium levofolinate	IGM Biosciences, Inc. (IGMS)
Camrelizumab and Cetuximab	Amneal Pharmaceuticals, Inc. (AMRX)
CAPOX	IGM Biosciences, Inc. (IGMS)
cetuximab	GH Research PLC (GHRS)
Cetuximab	KYNTRA BIO INC. (KYNB)
Cetuximab	Merck & Co., Inc. (MRK)
Cetuximab	Amneal Pharmaceuticals, Inc. (AMRX)
Cetuximab	BRISTOL MYERS SQUIBB CO (BMY)
Cetuximab	ENANTA PHARMACEUTICALS INC (ENTA)
Cetuximab	REGENXBIO Inc. (RGNX)
Cetuximab	Merus N.V. (MRUS)
Chemotherapy	IGM Biosciences, Inc. (IGMS)
Chemotherapy Regimen 1	BioNTech SE (BNTX)
Chemotherapy Regimen 2	BioNTech SE (BNTX)
CMAB009	IGM Biosciences, Inc. (IGMS)
Drug	Summit Therapeutics Inc. (SMMT)
Floxuridine	IGM Biosciences, Inc. (IGMS)
folfiri	Sanofi (SNY)
FOLFIRI	Amneal Pharmaceuticals, Inc. (AMRX)
FOLFIRI	IGM Biosciences, Inc. (IGMS)
FOLFIRI Protocol	IGM Biosciences, Inc. (IGMS)
folfiri regimen	Mirati Therapeutics, Inc. (MRTX)
folfiri regimen	AMGEN INC (AMGN)
FOLFIRI regimen	Merus N.V. (MRUS)
FOLFIRI regimen	IGM Biosciences, Inc. (IGMS)
FOLFIRI-HD	IGM Biosciences, Inc. (IGMS)
FOLFIRI+cetuximab	IGM Biosciences, Inc. (IGMS)
FOLFOX	Amneal Pharmaceuticals, Inc. (AMRX)
FOLFOX	IGM Biosciences, Inc. (IGMS)
FOLFOX	KYNTRA BIO INC. (KYNB)
FOLFOX	Merus N.V. (MRUS)
FOLFOX or FOLFIRI	IGM Biosciences, Inc. (IGMS)
FOLFOX-4	IGM Biosciences, Inc. (IGMS)
FOLFOX-7	IGM Biosciences, Inc. (IGMS)
FOLFOX+QL1706+Cetuximab	KYNTRA BIO INC. (KYNB)
Four week alternating FOLFOX and FOLFIRI	IGM Biosciences, Inc. (IGMS)
Fruquintinib	IGM Biosciences, Inc. (IGMS)
Fruquintinib Combined With Chemotherapy	IGM Biosciences, Inc. (IGMS)
fruquintinib+chemotherapy	IGM Biosciences, Inc. (IGMS)
gevokizumab	NOVARTIS AG (NVSEF)
Hormone Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
IBI351, cetuximab β combined with FOLFIRI	IGM Biosciences, Inc. (IGMS)
Leucovorin	BRISTOL MYERS SQUIBB CO (BMY)
Leucovorin	Amneal Pharmaceuticals, Inc. (AMRX)
Leucovorin Calcium	Amneal Pharmaceuticals, Inc. (AMRX)
leucovorin calcium/levoleucovorin	GH Research PLC (GHRS)
Leucovorin calcium/Levoleucovorin	REGENXBIO Inc. (RGNX)
mFOLFOX6	IGM Biosciences, Inc. (IGMS)
mfolfox6 regimen	Mirati Therapeutics, Inc. (MRTX)
mFOLFOXIRI	IGM Biosciences, Inc. (IGMS)
Modified FOLFOX-6 regimen	Merus N.V. (MRUS)
Molecular analysis of exon 9 and 20 of PI3K	Cidara Therapeutics, Inc. (CDTX)
panitumumab	GH Research PLC (GHRS)
Panitumumab	IGM Biosciences, Inc. (IGMS)
PD-1 Monoclonal Antibody	IGM Biosciences, Inc. (IGMS)
Postoperative reintroduction of FOLFIRI based chemotherapy	IGM Biosciences, Inc. (IGMS)
regorafenib	IGM Biosciences, Inc. (IGMS)
Sintilimab	IGM Biosciences, Inc. (IGMS)
Standard Chemotherapy	BioNTech SE (BNTX)
standard second-line chemotherapy	IGM Biosciences, Inc. (IGMS)
Standard systemic therapy	IGM Biosciences, Inc. (IGMS)
Systemic therapy	IGM Biosciences, Inc. (IGMS)
tak-113	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-113	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
TAS-102	Merus N.V. (MRUS)
Tiragolumab	IGM Biosciences, Inc. (IGMS)
tislelizumab	BeOne Medicines Ltd. (ONC)
Tislelizumab	BeOne Medicines Ltd. (ONC)
tremelimumab	CG Oncology, Inc. (CGON)
trifluridine/tipiracil	AbbVie Inc. (ABBV)
Tucatinib	PFIZER INC (PFE)
Young TIL	Filana Therapeutics Inc. (FLNA)

Phase 2(103)

Drug	Company
350 mg leronlimab	CytoDyn Inc. (CYDY)
5 FU bolus	IGM Biosciences, Inc. (IGMS)
5 FU continuous	IGM Biosciences, Inc. (IGMS)
5-fu	NuCana plc (NCNA)
700 mg leronlimab	CytoDyn Inc. (CYDY)
AB680	Arcus Biosciences, Inc. (RCUS)
Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5	CG Oncology, Inc. (CGON)
AK112	IGM Biosciences, Inc. (IGMS)
AK119	IGM Biosciences, Inc. (IGMS)
Aldesleukin	Filana Therapeutics Inc. (FLNA)
Amivantamab	IGM Biosciences, Inc. (IGMS)
Amivantamab IV	IGM Biosciences, Inc. (IGMS)
Avutometinib	ENANTA PHARMACEUTICALS INC (ENTA)
Biweekly FOLFIRI	REGENXBIO Inc. (RGNX)
Biweekly FOLFIRI	KYNTRA BIO INC. (KYNB)
Biweekly FOLFIRI	Merus N.V. (MRUS)
Biweekly Modified FOLFOX6	Merus N.V. (MRUS)
Biweekly Modified FOLFOX6	KYNTRA BIO INC. (KYNB)
Biweekly Modified FOLFOX6	REGENXBIO Inc. (RGNX)
Biweekly Modified FOLFOX6	IGM Biosciences, Inc. (IGMS)
BMS-986340	ENANTA PHARMACEUTICALS INC (ENTA)
cabozantinib	NOVARTIS AG (NVSEF)
Cabozantinib	ENANTA PHARMACEUTICALS INC (ENTA)
CAPOX	Merus N.V. (MRUS)
Cediranib	ASTRAZENECA PLC (AZN)
cetuximab	PFIZER INC (PFE)
cetuximab	Verastem, Inc. (VSTM)
cetuximab + mfolfox6	Verastem, Inc. (VSTM)
Cetuximab Sarotalocan Sodium	Merus N.V. (MRUS)
Dabrafenib plus Trametinib	ENANTA PHARMACEUTICALS INC (ENTA)
Defactinib	ENANTA PHARMACEUTICALS INC (ENTA)
denikitug	GILEAD SCIENCES, INC. (GILD)
Eliglustat+Immune checkpoint inhibitor	Crinetics Pharmaceuticals, Inc. (CRNX)
Eliglustat+Immune checkpoint inhibitor +Regorafenib	Crinetics Pharmaceuticals, Inc. (CRNX)
Elraglusib Oral Tablet	ACTUATE THERAPEUTICS, INC. (ACTU)
Emavusertib	ADMA BIOLOGICS, INC. (ADMA)
FLOX	ENANTA PHARMACEUTICALS INC (ENTA)
FLOX	Merus N.V. (MRUS)
Floxuridine	Merus N.V. (MRUS)
Floxuridine	BridgeBio Oncology Therapeutics, Inc. (BBOT)
folfiri	ASTRAZENECA PLC (AZN)
folfiri	ONCOLYTICS BIOTECH INC (ONCY)
folfiri	Novartis AG (NVS)
folfiri	Cardiff Oncology, Inc. (CRDF)
folfiri	Novartis AG (NVS)
FOLFIRI regimen	REGENXBIO Inc. (RGNX)
folfox	Cardiff Oncology, Inc. (CRDF)
FOLFOX	ENANTA PHARMACEUTICALS INC (ENTA)
FOLFOX regimen	KYNTRA BIO INC. (KYNB)
FOLFOX regimen	IGM Biosciences, Inc. (IGMS)
folinic acid	AbbVie Inc. (ABBV)
fosifloxuridine nafalbenamide	NuCana plc (NCNA)
Fosifloxuridine Nafalbenamide	IGM Biosciences, Inc. (IGMS)
Hydroxychloroquine	IGM Biosciences, Inc. (IGMS)
Immune checkpoint inhibitor	KYNTRA BIO INC. (KYNB)
Inavolisib	IGM Biosciences, Inc. (IGMS)
Iparomlimab and Tuvonralimab	IGM Biosciences, Inc. (IGMS)
Ivonescimab	IGM Biosciences, Inc. (IGMS)
leucovorin	KYNTRA BIO INC. (KYNB)
leucovorin	NuCana plc (NCNA)
Leucovorin	AbbVie Inc. (ABBV)
Leucovorin	Jazz Pharmaceuticals plc (JAZZ)
m-FOLFOX-6 regimen	Arcus Biosciences, Inc. (RCUS)
mFOLFOXIRI	Merus N.V. (MRUS)
mFOLFOXIRI	KYNTRA BIO INC. (KYNB)
mFOLFOXIRI	REGENXBIO Inc. (RGNX)
modified folfox6	Novartis AG (NVS)
navicixizumab	OncoMed Pharmaceuticals Inc (OMED)
ngm120 q4w	NGM BIOPHARMACEUTICALS INC (NGM)
ngm120 q8w	NGM BIOPHARMACEUTICALS INC (NGM)
nis793	Novartis AG (NVS)
NK Cells	FATE THERAPEUTICS INC (FATE)
Nogapendekin Alfa	CG Oncology, Inc. (CGON)
nuc-3373	NuCana plc (NCNA)
nuc-3373 + leucovorin	NuCana plc (NCNA)
nufiri	NuCana plc (NCNA)
Olaparib	Merus N.V. (MRUS)
ompenaclid	IGM Biosciences, Inc. (IGMS)
Ompenaclid	REGENXBIO Inc. (RGNX)
Ompenaclid	ENANTA PHARMACEUTICALS INC (ENTA)
Ompenaclid	Crinetics Pharmaceuticals, Inc. (CRNX)
Ompenaclid	Merus N.V. (MRUS)
onvansertib	Cardiff Oncology, Inc. (CRDF)
Onvansertib	IGM Biosciences, Inc. (IGMS)
Onvansertib (Onv)	Cardiff Oncology, Inc. (CRDF)
ot-101	Oncotelic Therapeutics, Inc. (OTLC)
ozekibart	Inhibrx Biosciences, Inc. (INBX)
panitumumab	AbbVie Inc. (ABBV)
panitumumab	Verastem, Inc. (VSTM)
Panitumumab	Merus N.V. (MRUS)
PDS01ADC	IGM Biosciences, Inc. (IGMS)
PDS01ADC	BridgeBio Oncology Therapeutics, Inc. (BBOT)
PM8002	BioNTech SE (BNTX)
Regorafenib+Immune checkpoint inhibitor	Crinetics Pharmaceuticals, Inc. (CRNX)
ro7198457	BioNTech SE (BNTX)
RO7198457 intravenous	BioNTech SE (BNTX)
sirexatamab	CYPHERPUNK TECHNOLOGIES INC. (CYPH)
TAS-102	AIM ImmunoTech Inc. (AIM)
tislelizumab	Novartis AG (NVS)
tisotumab vedotin	PFIZER INC (PFE)
Trifluridine + Tipiracil	ENANTA PHARMACEUTICALS INC (ENTA)
trifluridine-tipiracil	GILEAD SCIENCES, INC. (GILD)
ZN-c3	Zentalis Pharmaceuticals, Inc. (ZNTL)

Phase 1(79)

Drug	Company
177lu-pnt6555	POINT Biopharma Global Inc. (PNT)
Adagrasib	IGM Biosciences, Inc. (IGMS)
Aminolevulinic Acid	ENANTA PHARMACEUTICALS INC (ENTA)
amivantamab	GH Research PLC (GHRS)
Balstilimab	UNITED THERAPEUTICS Corp (UTHR)
BET Bromodomain Inhibitor ZEN-3694	Amneal Pharmaceuticals, Inc. (AMRX)
BET Bromodomain Inhibitor ZEN-3694	FATE THERAPEUTICS INC (FATE)
Botensilimab	UNITED THERAPEUTICS Corp (UTHR)
C-reactive protein and procalcitonin dosages	ENANTA PHARMACEUTICALS INC (ENTA)
cabozantinib	Novartis AG (NVS)
Cemiplimab	Crinetics Pharmaceuticals, Inc. (CRNX)
cetuximab	REVOLUTION MEDICINES, INC. (RVMD)
Cetuximab	Zentalis Pharmaceuticals, Inc. (ZNTL)
Chemotherapy	Syndax Pharmaceuticals Inc (SNDX)
CLR 121225	Cellectar Biosciences, Inc. (CLRB)
CT-202	Context Therapeutics Inc. (CNTX)
CUE-102	Cue Biopharma, Inc. (CUE)
Divarasib	IGM Biosciences, Inc. (IGMS)
Emavusertib	Amneal Pharmaceuticals, Inc. (AMRX)
Emavusertib	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Emavusertib	ENANTA PHARMACEUTICALS INC (ENTA)
Emavusertib	Merus N.V. (MRUS)
Encorafenib	Zentalis Pharmaceuticals, Inc. (ZNTL)
Encorafenib	ENANTA PHARMACEUTICALS INC (ENTA)
Encorafenib	FATE THERAPEUTICS INC (FATE)
Fludarabine	Amneal Pharmaceuticals, Inc. (AMRX)
folfiri	GH Research PLC (GHRS)
FOLFIRI	BridgeBio Oncology Therapeutics, Inc. (BBOT)
FOLFIRI	REGENXBIO Inc. (RGNX)
FOLFIRI	ENANTA PHARMACEUTICALS INC (ENTA)
folfox	GH Research PLC (GHRS)
folfox	Incyte Corp. (INCY)
FOLFOX	REGENXBIO Inc. (RGNX)
gevokizumab	Novartis AG (NVS)
GSK4418959	IDEAYA Biosciences, Inc. (IDYA)
hro761	NOVARTIS AG (NVSEF)
hro761	Novartis AG (NVS)
im-1617	Immunome Inc. (IMNM)
IMC-R117C (PIWIL-1)	Immunocore Holdings plc (IMCR)
inca33890	Incyte Corp. (INCY)
intrathecal chemotherapy	Syndax Pharmaceuticals Inc (SNDX)
JAB-21822	IGM Biosciences, Inc. (IGMS)
jnj-89402638	GH Research PLC (GHRS)
JNJ-89402638	IGM Biosciences, Inc. (IGMS)
JNJ-89402638	BridgeBio Oncology Therapeutics, Inc. (BBOT)
JNJ-89402638	ENANTA PHARMACEUTICALS INC (ENTA)
JNJ-89402638	REGENXBIO Inc. (RGNX)
JNJ-89402638	Merus N.V. (MRUS)
jnj-95437446	GH Research PLC (GHRS)
KRAS Vaccine with Poly-ICLC adjuvant	UNITED THERAPEUTICS Corp (UTHR)
leucovorin	PFIZER INC (PFE)
Leucovorin Calcium	ADMA BIOLOGICS, INC. (ADMA)
Leucovorin Calcium	CURIS INC (CRIS)
LPM6690176	IGM Biosciences, Inc. (IGMS)
me-344	Lite Strategy, Inc. (LITS)
modified folfox6	Novartis AG (NVS)
mrtx849	Mirati Therapeutics, Inc. (MRTX)
Muzastotug	IGM Biosciences, Inc. (IGMS)
panitumumab	AMGEN INC (AMGN)
PD-1 inhibitor	IDEAYA Biosciences, Inc. (IDYA)
pf-08046050	PFIZER INC (PFE)
pf-08046052	PFIZER INC (PFE)
Photodynamic Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
Pidnarulex	Crinetics Pharmaceuticals, Inc. (CRNX)
plogosertib (plogo)	Bio Green Med Solution, Inc. (BGMSP)
ProAgio	IGM Biosciences, Inc. (IGMS)
promitil	Rafael Holdings, Inc. (RFL)
Pumitamig	Merus N.V. (MRUS)
ramucirumab	Novartis AG (NVS)
ramucirumab	NOVARTIS AG (NVSEF)
Regorafenib	ENANTA PHARMACEUTICALS INC (ENTA)
Revumenib	Syndax Pharmaceuticals Inc (SNDX)
rmc-6236	REVOLUTION MEDICINES, INC. (RVMD)
rmc-9805	REVOLUTION MEDICINES, INC. (RVMD)
RP3	Replimune Group, Inc. (REPL)
SY-5609	IGM Biosciences, Inc. (IGMS)
tagmokitug	Coherus Oncology, Inc. (CHRS)
varsetatug masetecan	CytomX Therapeutics, Inc. (CTMX)
xmt-2056	Mersana Therapeutics, Inc. (MRSN)

Preclinical(17)

Drug	Company
cryptophycin-adc	Lantern Pharma Inc. (LTRN)
hb-700	HOOKIPA Pharma Inc. (HOOK)
imx-111	Immix Biopharma, Inc. (IMMX)
io112	IO Biotech, Inc. (IOBT)
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)
KRAS program	Cogent Biosciences, Inc. (COGT)
mapkapk2 inhibitor	METASTAT, INC. (MTST)
mink-215	MiNK Therapeutics, Inc. (INKT)
ngc-iri	Processa Pharmaceuticals, Inc. (PCSA)
Pan-mutant BRAF degrader program (proprietary)	Nurix Therapeutics, Inc. (NRIX)
Pan-mutant BRAF program (mutant BRAF degraders)	Nurix Therapeutics, Inc. (NRIX)
pan-ras	AIxCrypto Holdings, Inc. (AIXC)
pcs11t	Processa Pharmaceuticals, Inc. (PCSA)
PLP-33	CNBX Pharmaceuticals Inc. (CNBX)
RCC-33	CNBX Pharmaceuticals Inc. (CNBX)
theralink pan-tumor assay 2.0	THERALINK TECHNOLOGIES, INC. (THER)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)

Unknown(5)

Drug	Company
HSV1 viral therapeutic platform	Bullfrog AI Holdings Inc. (BFRG)
mfolfox6 + panitumumab combination therapy	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
mfolfox6 + panitumumab combination therapy	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
MyRisk	MYRIAD GENETICS INC (MYGN)
shield	Guardant Health Inc. (GH)

Early Phase 1(9)

Drug	Company
Encorafenib	Amneal Pharmaceuticals, Inc. (AMRX)
experimental	VERTEX PHARMACEUTICALS INC / MA (VRTX)
Panitumumab	Amneal Pharmaceuticals, Inc. (AMRX)
Sotorasib	Amneal Pharmaceuticals, Inc. (AMRX)
Sotorasib	IGM Biosciences, Inc. (IGMS)
Trifluridine/tipiracil	IGM Biosciences, Inc. (IGMS)
Trifluridine/tipiracil	Amneal Pharmaceuticals, Inc. (AMRX)
Tucatinib	Amneal Pharmaceuticals, Inc. (AMRX)
Tucatinib	IGM Biosciences, Inc. (IGMS)

N/A(2)

Drug	Company
N-Acetyl Cysteine	Merus N.V. (MRUS)
Vitamin D	Cidara Therapeutics, Inc. (CDTX)

Phase 1/Phase 2(20)

Drug	Company
amivantamab iv	GH Research PLC (GHRS)
cetuximab	Mirati Therapeutics, Inc. (MRTX)
cetuximab	Erasca, Inc. (ERAS)
ERAS-007	Erasca, Inc. (ERAS)
gcc19cart	Lyell Immunopharma, Inc. (LYEL)
imc-r117c	Immunocore Holdings plc (IMCR)
leucovorin	GH Research PLC (GHRS)
lyl273	Lyell Immunopharma, Inc. (LYEL)
mfolfirinox regimen	REVOLUTION MEDICINES, INC. (RVMD)
mfolfox6 regimen	REVOLUTION MEDICINES, INC. (RVMD)
nufiri + egfr inhibitor	NuCana plc (NCNA)
nufiri + vegf pathway inhibitor	NuCana plc (NCNA)
nufox	NuCana plc (NCNA)
nufox + egfr inhibitor	NuCana plc (NCNA)
nufox + vegf pathway inhibitor	NuCana plc (NCNA)
pelareorep	ONCOLYTICS BIOTECH INC (ONCY)
REC-617	RECURSION PHARMACEUTICALS, INC. (RXRX)
Regorafenib	Arcus Biosciences, Inc. (RCUS)
son-1210	SONNET BIOTHERAPEUTICS HOLDINGS, INC. (BURG)
tcr-t library	Alaunos Therapeutics, Inc. (TCRT)

Phase 2/Phase 3(7)

Drug	Company
Actimab-A	Actinium Pharmaceuticals, Inc. (ATNM)
CAPOX	BRISTOL MYERS SQUIBB CO (BMY)
CTX-009	Compass Therapeutics, Inc. (CMPX)
FOLFIRI	BRISTOL MYERS SQUIBB CO (BMY)
FOLFOX	BRISTOL MYERS SQUIBB CO (BMY)
granite	Gritstone bio, Inc. (GRTS)
tovecimig (CTX-009)	Compass Therapeutics, Inc. (CMPX)

Phase 4(12)

Drug	Company
5-FU	IGM Biosciences, Inc. (IGMS)
BMS-813160	BRISTOL MYERS SQUIBB CO (BMY)
Cetuximab	IGM Biosciences, Inc. (IGMS)
Cetuximab	Filana Therapeutics Inc. (FLNA)
Cetuximab wkly	IGM Biosciences, Inc. (IGMS)
Dapagliflozin along with standard medical therapy	ENANTA PHARMACEUTICALS INC (ENTA)
Folinic acid	IGM Biosciences, Inc. (IGMS)
Leucovorin and 5-FU	IGM Biosciences, Inc. (IGMS)
Leucovorin Calcium	IGM Biosciences, Inc. (IGMS)
Neoadjuvant olaparib	ASTRAZENECA PLC (AZN)
Olaparib	ASTRAZENECA PLC (AZN)
Xeloda	IGM Biosciences, Inc. (IGMS)

Compare drugs

alymsys vs calcium gluconate in alymsys vs Cyramza alymsys vs Erbitux

Frequently asked questions

How many drugs are in development for Colorectal?

BioSniper tracks 357 drugs in development for Colorectal across 96 companies.

How many clinical trials target Colorectal?

There are 1 clinical trial targeting Colorectal tracked by BioSniper.

What is the prevalence of Colorectal?

The estimated prevalence of Colorectal is approximately 135.0 per 100,000 population.

Deep-dive into Colorectal

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis